Characteristics, prognosis, and outcomes of cutaneous ischemia and gangrene in systemic necrotizing vasculitides: A retrospective multicenter study

Seminars in Arthritis and Rheumatism

Volumn 43, Issue 5, 2014, Pages 681-688

  Lega, Jean Christophe ^a,b   Seror, Raphaèle ^a   Fassier, Thomas ^b   Aumaître, Olivier ^c   Quere, Isabelle ^d   Pourrat, Jacques ^e   Gilson, Brigitte ^f   Sparsa, Agnes ^g   Wahl, Denis ^h,i,j   Le Jeunne, Claire ^a   Decaux, Olivier ^k   Mouthon, Luc ^a   Mahr, Alfred ^a   Cohen, Pascal ^a   Guillevin, Loïc ^a   Pagnoux, Christian ^a,l  

^a Institut Cochin   (France)

^b UNIVERSITÉ LYON 1   (France)

^c SERVICE DE RHUMATOLOGIE   (France)

^d HÔPITAL SAINT ELOI   (France)

^e CHU RANGUEIL   (France)

^f Centre Hospitalier de Verdun   (France)

^g DUPUYTREN UNIVERSITY HOSPITAL   (France)

^h UNIVERSITY HOSPITAL OF NANCY   (France)

ⁱ INSERM   (France)

^j UNIVERSITÉ DE LORRAINE   (France)

^k SERVICE DE RHUMATOLOGIE   (France)

^l UNIVERSITY OF TORONTO   (Canada)

more..

Author keywords

Cutaneous necrosis; Digital necrosis; Prognosis; Ulcers; Vasculitis

Indexed keywords

ANTITHROMBOCYTIC AGENT; CORTICOSTEROID; CYCLOPHOSPHAMIDE; HEPARIN;

ADULT; AMPUTATION; ARTHRALGIA; ARTICLE; CHURG STRAUSS SYNDROME; CORONARY ARTERY DISEASE; CUTANEOUS ISCHEMIA; DIGESTIVE SYSTEM PERFORATION; FEMALE; FOLLOW UP; GANGRENE; HUMAN; ISCHEMIA; MAJOR CLINICAL STUDY; MALE; MICROSCOPIC POLYANGIITIS; MORTALITY; NECROTIZING ARTERITIS; POLYARTERITIS NODOSA; PRIORITY JOURNAL; PROGNOSIS; RELAPSE; RETROSPECTIVE STUDY; SKIN MANIFESTATION; SKIN NECROSIS; SKIN ULCER; SMOKING; SYSTEMIC NECROTIZING VASCULITIS; SYSTEMIC VASCULITIS; WEGENER GRANULOMATOSIS; AGED; CLINICAL TRIAL; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; PREVALENCE; SKIN; VASCULARIZATION;

ADULT; AGED; FEMALE; GANGRENE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PROGNOSIS; RETROSPECTIVE STUDIES; SKIN; SYSTEMIC VASCULITIS;

EID: 84898827056     PISSN: 00490172     EISSN: 1532866X     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2013.09.001     Document Type: Article

References (41)

1. Jennette J.C., Falk R.J. Small-vessel vasculitis. N Engl J Med 1997, 337:1512-1523.
2. Luqmani R.A., Bacon P.A., Moots R.J., Janssen B.A., Pall A., Emery P., et al. Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. QJM 1994, 87:671-678.
3. Carlson J.A. The histological assessment of cutaneous vasculitis. Histopathology 2010, 56:3-23.
4. Leavitt R.Y., Fauci A.S., Bloch D.A., Michel B.A., Hunder G.G., Arend W.P., et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990, 33:1101-1107.
5. Lightfoot R.W., Michel B.A., Bloch D.A., Hunder G.G., Zvaifler N.J., McShane D.J., et al. The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum 1990, 33:1088-1093.
6. Masi A.T., Hunder G.G., Lie J.T., Michel B.A., Bloch D.A., Arend W.P., et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 1990, 33:1094-1100.
7. Jennette J.C., Falk R.J., Andrassy K., Bacon P.A., Churg J., Gross W.L., et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994, 37:187-192.
8. Guillevin L., Cohen P., Mahr A., Arene J.P., Mouthon L., Puechal X., et al. Treatment of polyarteritis nodosa and microscopic polyangiitis with poor prognosis factors: a prospective trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in sixty-five patients. Arthritis Rheum 2003, 49:93-100.
9. Guillevin L., Mahr A., Callard P., Godmer P., Pagnoux C., Leray E., et al. Hepatitis B virus-associated polyarteritis nodosa: clinical characteristics, outcome, and impact of treatment in 115 patients. Medicine (Baltimore) 2005, 84:313-322.
10. Guillevin L., Merrouche Y., Gayraud M., Jarrousse B., Royer I., Leon A., et al. Periarteritis nodosa related to hepatitis B virus. Determination of a new therapeutic strategy: 13 cases. Presse Med 1988, 17:1522-1526.
11. Guillevin L., Lhote F., Cohen P., Sauvaget F., Jarrousse B., Lortholary O., et al. Polyarteritis nodosa related to hepatitis B virus. A prospective study with long-term observation of 41 patients. Medicine (Baltimore) 1995, 74:238-253.
12. Guillevin L., Fain O., Lhote F., Jarrousse B., Le Thi Huong D., Bussel A., et al. Lack of superiority of steroids plus plasma exchange to steroids alone in the treatment of polyarteritis nodosa and Churg-Strauss syndrome. A prospective, randomized trial in 78 patients. Arthritis Rheum 1992, 35:208-215.
13. Pagnoux C., Mahr A., Hamidou M.A., Boffa J.J., Ruivard M., Ducroix J.P., et al. Azathioprine or methotrexate maintenance for ANCA-associated vasculitis. N Engl J Med 2008, 359:2790-2803.
14. Guillevin L., Lhote F., Gayraud M., Cohen P., Jarrousse B., Lortholary O., et al. Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients. Medicine (Baltimore) 1996, 75:17-28.
15. Gayraud M., Guillevin L., le Toumelin P., Cohen P., Lhote F., Casassus P., et al. Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients. Arthritis Rheum 2001, 44:666-675.
16. Guillevin L., Pagnoux C., Seror R., Mahr A., Mouthon L., Le Toumelin P. The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort. Medicine (Baltimore) 2011, 90:19-27.
17. Hellmich B., Flossmann O., Gross W.L., Bacon P., Cohen-Tervaert J.W., Guillevin L., et al. EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis. Ann Rheum Dis 2007, 66:605-617.
18. Merkel P.A., Lo G.H., Holbrook J.T., Tibbs A.K., Allen N.B., Davis J.C., et al. Brief communication: high incidence of venous thrombotic events among patients with Wegener granulomatosis: the Wegener's Clinical Occurrence of Thrombosis (WeCLOT) Study. Ann Intern Med 2005, 142:620-626.
19. Frances C., Du L.T., Piette J.C., Saada V., Boisnic S., Wechsler B., et al. Wegener's granulomatosis. Dermatological manifestations in 75 cases with clinicopathologic correlation. Arch Dermatol 1994, 130:861-867.
20. Daoud M.S., Gibson L.E., DeRemee R.A., Specks U., el-Azhary R.A., Su W.P. Cutaneous Wegener's granulomatosis: clinical, histopathologic, and immunopathologic features of thirty patients. J Am Acad Dermatol 1994, 31:605-612.
21. Hu C.H., O'Loughlin S., Winkelmann R.K. Cutaneous manifestations of Wegener granulomatosis. Arch Dermatol 1977, 113:175-182.
22. Aymard B., Bigard M.A., Thompson H., Schmutz J.L., Finet J.F., Borrelly J. Perianal ulcer: an unusual presentation of Wegener's granulomatosis. Report of a case. Dis Colon Rectum 1990, 33:427-430.
23. Thomas R.H., Payne C.M., Black M.M. Wegener's granulomatosis presenting as pyoderma gangrenosum. Clin Exp Dermatol 1982, 7:523-527.
24. Choi S.W., Lew S., Cho S.D., Cha H.J., Eum E.A., Jung H.C., et al. Cutaneous polyarteritis nodosa presented with digital gangrene: a case report. J Korean Med Sci 2006, 21:371-373.
25. Reed W.B., Jensen A.K., Konwaler B.E., Hunter D. The cutaneous manifestations in Wegener's granulomatosis. Acta Derm Venereol 1963, 43:250-264.
26. Otani Y., Anzai S., Shibuya H., Fujiwara S., Takayasu S., Asada Y., et al. Churg-Strauss syndrome (CSS) manifested as necrosis of fingers and toes and liver infarction. J Dermatol 2003, 30:810-815.
27. Sharma B.K., Daga M.K., Sharma M. A limited form of Churg-Strauss syndrome presenting without asthma and eosinophilia. Med J Aust 2004, 181:498-499.
28. Ferenczi K., Chang T., Camouse M., Han R., Stern R., Willis J., et al. A case of Churg-Strauss syndrome associated with antiphospholipid antibodies. J Am Acad Dermatol 2007, 56:701-704.
29. Boopathy K.S., Rajendran C.P., Rukmangatharajan S., Rajeswari S., Ravichandran R., Vasanthy N. Churg-Strauss syndrome with peripheral gangrene and severe renal failure. Int J Rheum Dis 2008, 188-191.
30. Inui S., Itami S., Iwai C., Yoshikawa K. Churg-Strauss syndrome involving medium-sized arteries. J Dermatol 2001, 28:161-164.
31. Binder C., Schattenkirchner M., Kruger K. Severe toe gangrene as an early manifestation of Wegener granulomatosis in a young patient. Z Rheumatol 1998, 57:227-230.
32. Maia M., Brandao P., Monteiro P., Barreto P., Brandao D., Ferreira J., et al. Upper limb ischemia in a patient with Wegener's granulomatosis. Interact Cardiovasc Thorac Surg 2008, 7:1137-1140.
33. Leung A., Sung C.B., Kothari G., Mack C., Fong C. Utilisation of plasma exchange in the treatment of digital infarcts in Wegener's granulomatosis. Int J Rheum Dis 2010, 13:e59-e61.
34. Kejriwal R., Lim T.M., Kumar S. Wegener's granulomatosis and acute upper limb digital ischemia. Int J Rheum Dis 2008, 11:185-187.
35. Bessias N., Moulakakis K.G., Lioupis C., Bakogiannis K., Sfyroeras G., Kakaletri K., et al. Wegener's granulomatosis presenting during pregnancy with acute limb ischemia. J Vasc Surg 2005, 42:800-804.
36. Shimbo J., Miwa A., Aoki K. Cryofibrinogenemia associated with polyarteritis nodosa. Clin Rheumatol 2006, 25:562-563.
37. Zulian F., Corona F., Gerloni V., Falcini F., Buoncompagni A., Scarazatti M., et al. Safety and efficacy of iloprost for the treatment of ischaemic digits in paediatric connective tissue diseases. Rheumatology (Oxford) 2004, 43:229-233.
38. Avcin T., Singh-Grewal D., Silverman E.D., Schneider R. Severe digital ischaemia in a child with Wegener's granulomatosis. Scand J Rheumatol 2007, 36:78-80.
39. Pagnoux C., Chironi G., Simon A., Guillevin L. Atherosclerosis in ANCA-associated vasculitides. Ann N Y Acad Sci 2007, 1107:11-21.
40. Ruffolo A.J., Romano M., Ciapponi A. Prostanoids for critical limb ischaemia. Cochrane Database Syst Rev 2010, 1. [CD006544].
41. Hudson M., Lo E., Baron M., Steele R. Modeling smoking in systemic sclerosis: a comparison of different statistical approaches. Arthritis Care Res 2011, 63:570-578.